A Prospective Phase II Study of Thalidomide, Cyclophosphamide and Prednisone in Newly Diagnosed Idiopathic Multicentric Castleman's Disease | |
Zhang, Lu; Zhao, Ai-Lin; Feng, Jun; Cao, Xinxin; Zhang, Yan; Zhu, Tienan; Duan, Minghui; Zhou, Daobin; Li, Jian | |
2018 | |
卷号 | 132 |
ISSN号 | 0006-4971 |
DOI | 10.1182/blood-2018-99-113528 |
URL标识 | 查看原文 |
收录类别 | SCIE |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6349556 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Zhang, Lu,Zhao, Ai-Lin,Feng, Jun,et al. A Prospective Phase II Study of Thalidomide, Cyclophosphamide and Prednisone in Newly Diagnosed Idiopathic Multicentric Castleman's Disease[J],2018,132. |
APA | Zhang, Lu.,Zhao, Ai-Lin.,Feng, Jun.,Cao, Xinxin.,Zhang, Yan.,...&Li, Jian.(2018).A Prospective Phase II Study of Thalidomide, Cyclophosphamide and Prednisone in Newly Diagnosed Idiopathic Multicentric Castleman's Disease.,132. |
MLA | Zhang, Lu,et al."A Prospective Phase II Study of Thalidomide, Cyclophosphamide and Prednisone in Newly Diagnosed Idiopathic Multicentric Castleman's Disease".132(2018). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论